Katie Peng
Fortuna: 2 M $ al 31/08/2026
Fortuna: 2 M $ al 31/08/2026
Ms. Katie Peng is an Independent Director at Scholar Rock Holding Corp., an Independent Director at Adicet Bio, Inc. and a Chief Commercial Officer at Denali Therapeutics, Inc. She is on the Board of Directors at Scholar Rock Holding Corp., Adicet Bio, Inc. and California Life Sciences Association.
Ms. Peng was previously employed as a General Manager by Roche Products Ltd. (Taiwan), a General Manager by Roche Singapore Pte Ltd., and a Senior Vice President & Head-OMNI Business Unit by Genentech, Inc. She received her undergraduate degree from the University of California, Berkeley and an MBA from Kelley School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/07/2026 | 34.301 ( 0,03 % ) | 2 M $ | 31/08/2026 | |
| 21/06/2026 | 368 ( 0 % ) | 3 202 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 27/09/2021 |
| ADICET BIO, INC. | Director/Miembro de la Junta | 10/07/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Miembro de la Junta | 15/02/2024 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Roche Products Ltd. (Taiwan) | Director Ejecutivo | 01/03/2017 |
Roche Singapore Pte Ltd.
Roche Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops new medicines and diagnostics solutions | Director Ejecutivo | 01/03/2015 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Singapore Pte Ltd.
Roche Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops new medicines and diagnostics solutions | Health Technology |
Roche Products Ltd. (Taiwan) | |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Adicet Bio, Inc.
Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.